IX Congress with international participation «Development of pharmacoeconomics and pharmacoepidemiology in the Russian Federation», 16-17 March 2015, Ufa

Lysova D.P., Lysova M.P., Miheeva N.V., Reshetko O.V. 3407

Pharmacoepidemiological analysis of secondary prevention of cerebral infarction according to age

Dolotovskaya P.V., Novikov D.E., Reshetko O.V., Furman N.V. 3297

Comparative analysis of the impact on the prognosis of patients with acute coronary syndrome drugs with proven efficacy in clinical practice

Baytman T.P., Ivlichev A.V., Levitan A.I., Reshetko O.V. 3384

Analysis of the actual practice of pharmacotherapy in patients with gastric ulcer and 12 duodenal ulcer in a central district hospital conditions

Miroshnichenko Y.V., Scherba M.P. 3565

Socio-economic analysis of the range of procurement of oral hypoglycemic agents in the military health care (the example of the western military region)

Kononov V.N., Miroshnichenko Y.V., Mustaev O.Z., Radionov E.O. 3599

Justification of the choice of drugs when refinement of medical cases

Goryachev A.B., Merkulov A.V., Miroshnichenko Y.V., Tihonov A.V. 3497

The new system of rationing drugs for russian navy

Goryachev A.B., Klochkova I.V., Miroshnichenko Y.V. 3362

The methodological approaches to the formation of armed forces first-aid kits and emergency medical cases

Reshetko O.V., Yakimova Y.N. 3268

Antibacterials for systemic use in the restrictive list of medicines

Reshetko O.V., Chernaya E.V. 3305

Estimation of structure destination of hypoglycemic agents in patients with type 2 diabetes mellitus and arterial hypertension

Ugrekhelidze D.T., Khabriev R.U., Yagudina R.I. 3628

Analysis of international experience of health technology assessment at the regional level

Ugrekhelidze D.T., Khabriev R.U., Yagudina R.I. 3544

Analysis of international experience of health technology assessment at the level of healthcare institutions

Kulikov A.Y., Ugrekhelidze D.T. 3215

Effect of different types of post-stroke spasticity therapy on decrease of economic losses of society

Sorokovikov I.V., Yagudina R.I. 3356

Pharmacoeconomic research of the use of the regimens of chemotherapy regimens in patients with multi-drug and extensively drug-resistant

Sanina I.I. 3256

Features of pharmacotherapy of infectious diseases during pregnancy in ambulatory practice

Kontsevaya A.V., Romanenko T.S. 3321

Low efficiency of antihypertensive therapy in patients of specialized cardiological institution as a factor of the irrational use of health care resources

Komarov E.A., Pochuprina A.A. 3177

Analysis of the effectiveness of the treatment of patients suffering from systemic lupus erythematosus

Pochuprina A.A. 3243

Cost analysis in patients with systemic lupus erythematosus in the Russian Federation

Pochuprina A.A., Protsenko M.V. 3318

Estimates of costs for correction of side effects arising from the use of ace inhibitors in patients with hypertension in the Russian Federation

Panfilova A.L. 3357

Analysis of indicators "willingness to pay threshold" in the health care system and pharmaceutical provision in Ukraine

Kulikov A.Y., Novikov I.V. 3278

Economic evaluation of glp-1 analogs as add-on to metformin therapy of diabetes mellitus

Kulikov A.Y., Novikov I.V. 3404

Economic evaluation of liraglutide as add-on to metformin therapy of diabetes mellitus

Kulikov A.Y., Novikov I.V. 3537

comparative pharmacoeconomic evaluation of drugs of the DPP-4 inhibitors

Murashko Y.I., Spichak I.V. 3363

Pharmacoeconomic study of drug supply of pregnant women with acute respiratory viral infections

Miheeva N.V., Reshetko O.V. 3350

Clinical and pharmacoeconomic efficiency thrombolytic therapy of cerebral infarction in clinical practice

Miheeva N.V., Reshetko O.V., Rizhenkova I.G. 3155

The effect of age of patients on pharmacotherapy of cerebrovascular accident in hospital

Ardenova N.N., Levitan A.I., Reshetko O.V. 3260

Pharmacoepidemiological analysis of pharmacotherapy of comorbid pathology of the musculoskeletal system in patients with rheumatoid arthritis

Komarov E.A. 3241

Health technology assessment in the treatment of bipolar disorder in the russian health care in terms of their impact on the budget

Komarov E.A. 3169

Estimation of consumption of atypical antipsychotic drugs used in the treatment of bipolar disorder, by analyzing the average daily maintenance dose (DDD)

Kulikov A.Y., Makarova E.I. 3325

The relevance of pharmacoeconomic evaluation of advantages of the application of easyhalers in bronchial asthma

Zolotovskaia I.A. 3189

Clinico-pharmacological justification for the use of anticoagulation in patients with atrial fibrillation undergoing cardioembolic stroke

Dereglazova Y.S., Spichak I.V. 3263

Pharmacoeconomic analysis of drug supply of children with juvenile arthritis

Babiy V.V., Yagudina R.I. 3532

The relevance of the pharmacoeconomic evaluation of highly active antiretroviral therapy (HAART) HIV-infected patients in the Russian Federation

Akimova Y.I. 3195

Budget impact analysis of the use of five-component and three component combination vaccines with acellular pertussis component in the regional calendar of preventive vaccinations as an example of Krasnodar for children at risk group

Abdrashitova G.T., Serpik V.G. 3356

IX Congress with international participation «Development of pharmacoeconomics and pharmacoepidemiology in the Russian Federation»
16-17 March 2015 year, Ufa